Hygieia Pharmaceuticals
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hygieia Pharmaceuticals - overview
Established
2021
Location
Shanghai, Shanghai, China
Primary Industry
Biotechnology
About
Founded in 2021 and based in Shanghai, China, Hygieia Pharmaceuticals is a biopharmaceutical company that focuses on the construction of siRNA delivery technology platform. In Seotember 2024, the firm closed a series A2 funding. The company's main products include MVIP delivery platform, DDP delivery platform and NSDP delivery platform. DDP is a second-generation siRNAs delivery technology platform developed by Hejia for liver diseases.
The company is also developing drugs to treat liver disease, cardiovascular and cerebrovascular and metabolic diseases. The company’s revenue is generated by providing siRNA delivery technology platform and coupled delivery of siRNA small nucleic acid drugs. The company will use the funding for the development of multiple Phase I clinical pipelines to provide additional funding for the development of more IND enabling projects and to improve the early research and development of extrahepatic delivery platform technology.
Current Investors
Tasly Capital, Leading Capital, Huangpu Biomedical Investment
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.hygieiapharma.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.